Bassett C.N., Neely M.D., Sidell K.R., Markesbery, W.R., Swift L.L., and Montine T.J. (1999) Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer’s disease and are neurotoxic when oxidized ex Vivo. Lipids 34: 1273-1280.
Beffert U., Danik M., Krzywkowski P., Ramassamy C., Berrada F. and Poirier J. (1998) The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer’s disease, Brain Res. Rev. 27: 119-142.
Behl C. (1999a) Alzheimer’s disease and oxidative stress: implications for novel therapeutic approaches. Progr. Neurobiology. 57: 301-323.
Behl C. (1999b) Vitamin E and other antioxidants in neuroprotection. Intl. J. Vit. Nutri. Res. 69: 213-219.
Borovic S., Zarkovic N., Wildburger R., Tatzber F., Jurin M. (1995) Post-traumatic differences in the titer of autoantibodies against oxidized low density lipoproteins (OLDL) in the sera of patients with bone fracture and traumatic brain injury. Periodicum Biol. 97:209-293:1995.
Butterfield D.A. (1997) Beta amyloid associated free radical oxidative stress and neurotoxicity – Implication for Alzheimer’s disease. Chem. Res. Toxicol. 10: 495-506.
Chanvitayapongs S., Draczynska-Lusiak B., and Sun A.Y. (1997) Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. NeuroReport 8:1499-1502.
Cheng Y., Chen M., Wixom P., and Sun A.Y. (1994) Extracellular ATP may induce neuronal degeneration by a free radical mechanism. Ann. N.Y. Acad. Sci. 738: 431-435.
Cheng Y., and Sun A.Y. (1994). Oxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons. Neurochemical Research. 19(12):1557-1564.
Draczynska-Lusiak B., Chen Y.M., and Sun A.Y. (1998a) Oxidized lipoproteins activate NF-kB binding activity and apoptosis in PC12 cells. NeuroReport 9:527-532.
Draczynska-Lusiak B., Doung A., and Sun A.Y. (1998b) Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease. Mol. Chem. Neuropath. 33:139-148.
Evans J.P., Whiteman M., Tredger J.M., and Halliwell B. (1997) Antioxidant properties of s-adenosyl-L-methionine: A proposed addition to organ storage fluids. Free Rad. Biol. & Med. 23: 1002-1008.
Fagan-Niven A., Bu G., Sun Y., Daugherty A., Holtzman D.M. (1996) ApoE-containing HDL promotes neurite outgrowth and is a liqand for the low density lipoprotein receptor-related protein (LRP). J. Biol. Chem. 271: 30121-30125.
Frankel E.N., Waterhouse A.L., and Kinsella J.E. (1993) Inhibition of human low-density lipoprotein oxidation by resveratrol. Lancet 341:1103-1104.
Fremont L. (2000) Biological effects of resveratrol. Life Sci. 66: 663-673.
Hesse L., Beher D., Masters C.L., and Multhaup G. (1994). The beta amyloid precursor protein binding to copper. FEBS Letters 349(1): 511-516.
Holtzman D.M., Pitas R.E., Nathan B., Mahley R.W., Bu G., and Schwartz A.L. (1995) LRP mediates apolipoprotein E-dependent neurite outgrowth in a CNS-derived neuronal cell line. Proc. Natl., Acad., Sci. USA 92: 9480-9484.
Hu J., Akama K.T., Kraft G.A., Chromy B.A., and Van Eldik L.J. (1998) Amyloid-beta peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release. Brain Res. 785: 195-206.
Huang X., Atwood C.S., Goldstein L.E., Hartshorn M.A., Moir R.D., Multhaup G., Tanzi R.E. and Bush A.I. (1997). Alzheimer Ab peptides simultaneously reduce metals and produce reactive oxygen species. Soc. Neurosci. Abstr. 648.7, 1663.
Huang X., Atwood C.S., Hartshorn M.A.,Multhaup G., Goldstein L.E., Scarpa R.C., Cuajungco M.P., Gray N.D.,Lim J., Moir R.D., Tanzi R.E. and Bush A.I.(1999a). The Ab peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38:7609-7616.
Huang X.D., Cuajungco M.A., Atwood C.S., et al (1999b) Cu(II) potentiation of Alzheimer A beta neurotoxicity—Correlation with cell free hydrogen peroxide production and metal reduction. J. Biol. Chem. 274: 37111-37116
Ignatius M.J., Gebicker-Haerter P.J., Skene J.H., Schilling J.W., Weisgraber K.H. and Shooter E.M. (1986) Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Nat´l. Acad. Sci. USA 83:1125-1129.
Ignatius M.J., Shooter E.M., Pitas R.E. and Mahley R.W. (1987) Lipoprotein uptake by neuronal growth cones in vitro. Science 236:959-962.
Kardos J., Kovacs I., Hajos F., Kalman M. and Simonyi M. (1989). Nerve endings from rat brain tissue release copper upon depolarization. A possible role in regulating neuronal excitability. Neuroscience Letters 103(2): 139-141.
Keller J.N., Hanni K.B. and Markesbery W.R. (1999a). Oxidized low-density lipoprotein induces neuronal cell death: implication for calcium, reactive oxygen species and caspases. J.Neurochem. 72:2601-2609.
Keller J.N., Hanni K.B. and Markesbery W.R. (1999b). 4-hydroxynonenal increases neuronal susceptibility to oxidative stress. J. Neurosci. Res. 58: 823-830.
Keller J.N., Hanni K.B., Gabbita S.P., Friebe V., Mattson M.P. and Kindy M.S. (1999c) Oxidized lipoproteins increase reactive oxygen species formation in microglia and astrocyte cell lines. Brain Res. 830: 10-15.
LaDu M.J., Gilligan S.M., Lukens J.R., Cabana V.G., Reardon C.A., Van Eldik L.J. and Holtzman D.M. (1998) Nascent astrocyte particles differ from lipoproteins in CSF. J. Neurochem. 70:2070-2081.
Li X. and Sun A.Y. (1999) Paraquat induced activation of transcription factor AP-1 and apoptosis in PC12 cells. J. Neurotransm. 106:1-21.
Lyras L., Cairns N.J., Jenner A., Jenner P. and Halliwell B.(1997) An assessment of oxidative damage to proteins, lipids and DNA in brain from patients with Alzheimer´s disease. J. Neurochem. 68:2061-2069.
Mark R.J., Fuson K.S. and May P.C. (1999) Characterization of 8-epiprostaglandin F-2 alpha as a marker of amyloid beta peptide-induced oxidative damage. J. Neurochem. 72: 1146-1153.
Mattson M.P., and Pedersen W.A. (1998) Effects of amyloid precursor protein derivatives and oxidative stress on basal forbrain cholinergic systems in Alzheimer’s disease. Int. J. Devel. Neurosci. 16: 737-753.
Mattson M.P. (1998) Free radicals, calcium, and synaptic plasticity-cell death continium: emerging roles of the transcription factor NF kappa B. Int. Rev. Neurobiology 42: 103-168.
Mattson M.P. and Goodman Y. (1995) Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res.
676:219-224.
Mucke L., Masliah E., Johnson W.B., Ruppe M.D., Alford M., Rockenstein E.M., Forss-Petter S., Pietropaulo M., Mallory M. and Abraham C.R. (1994). Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice. Brain Research 666(2):151-167.
Neely M.D., Sidell K.R., Graham D.G. and Montine T.J. (1999) The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J. Neurochem. 72: 2323-2333.
Pitas R.E., Boyles J.K., Lee S.H., Foss D. and Mahley R.W. (1987a) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoprotein. Biochim. Biophys. Acta 917:148-161.
Pitas R.E., Boyles J.K., Lee S.H., Hui D.and Weisgraber K.H.(1987b), Lipoproteins and their receptors in the central nervous system. J. Biol. Chem. 262:14352-14360.
Pitas R.E., Innerarity L. and Weinstein J.N. (1981) Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis. 1:177-185.
Poirier J., Baccichet A., Dea D. and Gauthier S. (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodeling in hippocampus in adult rats. Neuroscience. 55:81-90.
Price D.L., Sisodia S.S., and Borchelt D.R. (1998) Genetic neurodegenerative diseases: The human illness and transgenic models. Sci. 282: 1079-1083.
Rensen P.C.N., Schiffelers R.M., Versluis A.J., Bijsterbosch M.K., Van Kuijk-Meuwissen E.M.J. and Van Berkel T.J.C. (1997) Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoprotein as carriers for the site-specific delivery of antitumor agents. Mol. Pharmacol. 52: 445-455.
Sayre L.M., Zalasko D.A., Harris P.L.R., Perry G., Salomon R.G. and Smith M.A. (1997) 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer´s disease. J. Neurochem. 68:2092-2097.
Smith M.A., Harris D.L.R., Sayre L.M., Beckman J.S. and Perry G.. (1997), Widespread peroxynitrite-mediated damage in Alzheimer´s disease. J. Neurosci. 17:2653-2657.
Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S. Roses A.D. (1993b) Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer´s disease. Proc. Natl. Acad. Sci. USA 90:1977-1981.
Strittmatter W.J., Weisgraber K.H., Huang D.Y. et al. (1993a) Binding of human apolipoprotein E to synthetic amyloid beta peptides: isoform specific effects and implication for late-onset Alzheimer´s disease. Proc. Natl. Acad. Sci. USA 90:8098-8102.
Sun A.Y., Chen Y.M. and Lusiak B. (1998) The protective action of resveratrol on apoptotic cell death induced by oxidized lipoproteins. in Biological Oxidants and Antioxidants: Molecular Mechanism and Health Effect (L. Packard, ed.) AOCS Press, Champaign IL pp. 210-222.
Sun A.Y. and Chen Y.M. (1998). Oxidative stress and neurodegenerative disorders. J.Biomed. Sci. 5(6):401-414
Sun A.Y., and Sun G.Y., (1976) Functional roles of phospholipids of synaptosomal membrane. In: “Functional and Metabolism of Phospholipids in the Central and Peripheral Nervous Systems” (Porcellati G., Amaducci L and Galli C, eds) Plenum Publishing Corporation, New York, pp.169-197.
Yankner B.A. (1996) Mechanisms of neuronal degeneration in Alzheimer´s disease. Neuron 16:921-932.
Yatin S.M., Aksenov M. and Butterfield D.A.(1999). The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer’s disease. Neurochemical Research 42(3):427-435.
